British Patient Capital approves $30m commitment

The UK government-backed investor has committed to a TMT focused venture/growth capital fund.

Institution: British Patient Capital
Headquarters: Sheffield, UK
AUM: £7.3 billion

British Patient Capital, a subsidiary of British Business Bank, has committed $30 million to Hoxton Ventures III, according to a press release from the firm.

Fund III, which is managed by Hoxton Ventures, will invest into technology and life sciences companies across Western Europe. The fund has raised $208 million of its $225 million target.

As shown below, British Patient Capital tends to focus its private equity commitments on venture capital and growth equity vehicles globally.

Platinum subscribers may click here for the investor’s full profile, including key contacts, allocation strategy and fund investments.